Skip to main content
. 2020 Apr 9;35(4):455–467. doi: 10.1007/s12250-020-00199-1

Fig. 5.

Fig. 5

Protective efficacy of cVLPs against NDV NA-1 strain, Herts/33 strain and AIV H9N2 challenge. Survival rate (A), Body weight change (B) and the number of positive tissue samples (C) were recorded after NDV NA-1 strain challenge. Survival rate (D), Body weight change (E) and the number of positive tissue samples (F) were recorded after NDV Herts/33 strain challenge. Survival rate (G), body weight change (H) and the number of positive tissue samples (I) were recorded after AIV H9N2 challenge.